Aug 16, 2021 7:00am EDT Matinas BioPharma Announces Issuance of U.S. Patent Protecting MAT2203 to Treat or Prevent Cryptococcus Infections
Aug 10, 2021 6:31am EDT Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
Jul 27, 2021 7:00am EDT Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2021 Financial and Operational Results on August 10, 2021
May 10, 2021 6:30am EDT Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
Apr 28, 2021 7:30am EDT Matinas BioPharma to Participate in 7th Annual Truist Securities Life Sciences Summit
Apr 27, 2021 7:30am EDT Matinas BioPharma to Webcast Conference Call Discussing First Quarter 2021 Financial and Operational Results on May 10, 2021
Mar 29, 2021 6:30am EDT Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
